The absence of any new SARS-CoV-2 variant of concern designations by the WHO since March 2023 underpins the 81.5% trader consensus on “No.” Ongoing genomic surveillance continues to track Omicron sublineages such as BA.3.2 and XFG, which show notable spike mutations and have increased in detections across multiple countries since late 2025. Yet these strains remain classified only as variants under monitoring, with no evidence of substantially higher severity, immune escape, or transmission rates that would trigger a new concern label. Endemic circulation patterns and updated 2025–2026 vaccines aligned to dominant lineages further reinforce expectations that any further evolution will stay within existing categories through 2026.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertJa
$238,975 Vol.
$238,975 Vol.
31. Dez. 2026
Ja
$238,975 Vol.
$238,975 Vol.
31. Dez. 2026
This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.The absence of any new SARS-CoV-2 variant of concern designations by the WHO since March 2023 underpins the 81.5% trader consensus on “No.” Ongoing genomic surveillance continues to track Omicron sublineages such as BA.3.2 and XFG, which show notable spike mutations and have increased in detections across multiple countries since late 2025. Yet these strains remain classified only as variants under monitoring, with no evidence of substantially higher severity, immune escape, or transmission rates that would trigger a new concern label. Endemic circulation patterns and updated 2025–2026 vaccines aligned to dominant lineages further reinforce expectations that any further evolution will stay within existing categories through 2026.
This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Markt eröffnet: Dec 1, 2025, 4:49 PM ET
Volumen
$238,975Enddatum
31. Dez. 2026Markt eröffnet
Dec 1, 2025, 4:49 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.The absence of any new SARS-CoV-2 variant of concern designations by the WHO since March 2023 underpins the 81.5% trader consensus on “No.” Ongoing genomic surveillance continues to track Omicron sublineages such as BA.3.2 and XFG, which show notable spike mutations and have increased in detections across multiple countries since late 2025. Yet these strains remain classified only as variants under monitoring, with no evidence of substantially higher severity, immune escape, or transmission rates that would trigger a new concern label. Endemic circulation patterns and updated 2025–2026 vaccines aligned to dominant lineages further reinforce expectations that any further evolution will stay within existing categories through 2026.
This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Volumen
$238,975Enddatum
31. Dez. 2026Markt eröffnet
Dec 1, 2025, 4:49 PM ETResolver
0x65070BE91...The absence of any new SARS-CoV-2 variant of concern designations by the WHO since March 2023 underpins the 81.5% trader consensus on “No.” Ongoing genomic surveillance continues to track Omicron sublineages such as BA.3.2 and XFG, which show notable spike mutations and have increased in detections across multiple countries since late 2025. Yet these strains remain classified only as variants under monitoring, with no evidence of substantially higher severity, immune escape, or transmission rates that would trigger a new concern label. Endemic circulation patterns and updated 2025–2026 vaccines aligned to dominant lineages further reinforce expectations that any further evolution will stay within existing categories through 2026.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen